Artículos por temáticas

A personal 35 year perspective on Gilles de la Tourette syndrome: prevalence, phenomenology, comorbidities, and coexistent psychopathologies.

Robertson MM.

Lancet Psychiatry. 2015 Jan;2(1):68-87. doi: 10.1016/S2215-0366(14)00132-1. Review. Erratum in: Lancet Psychiatry. 2015 Apr;2(4):291.

Sensory phenomena related to tics, obsessive-compulsive symptoms, and global functioning in Tourette syndrome.

Kano Y, Matsuda N, Nonaka M, Fujio M, Kuwabara H, Kono T.

Compr Psychiatry. 2015 Oct;62:141-6. doi: 10.1016/j.comppsych.2015.07.006.

The role of GRIN2B in Tourette syndrome: Results from a transmission disequilibrium study.

Che F, Zhang Y, Wang G, Heng X, Liu S, Du Y.

J Affect Disord. 2015 Nov 15;187:62-5. doi: 10.1016/j.jad.2015.07.036.

Association of ADORA1 rs2228079 and ADORA2A rs5751876 Polymorphisms with Gilles de la Tourette Syndrome in the Polish Population.

Janik P, Berdyński M, Safranow K, Żekanowski C.

PLoS One. 2015 Aug 28;10(8):e0136754. doi: 10.1371/journal.pone.0136754.

Analysis of SLITRK1 in Japanese patients with Tourette syndrome using a next-generation sequencer.

Inai A, Tochigi M, Kuwabara H, Nishimura F, Kato K, Eriguchi Y, Shimada T, Furukawa M, Kawamura Y, Sasaki T, Kakiuchi C, Kasai K, Kano Y.

Psychiatr Genet. 2015 Dec;25(6):256-8. doi: 10.1097/YPG.0000000000000104.

Meta-Analysis: Risk of Tics Associated With Psychostimulant Use in Randomized, Placebo-Controlled Trials.

Cohen SC, Mulqueen JM, Ferracioli-Oda E, Stuckelman ZD, Coughlin CG, Leckman JF, Bloch MH.

J Am Acad Child Adolesc Psychiatry. 2015 Sep;54(9):728-36. doi: 10.1016/j.jaac.2015.06.011.

Serial pharmacological prescribing practices for tic management in Tourette syndrome.

Farag M, Stern JS, Simmons H, Robertson MM.

Hum Psychopharmacol. 2015 Nov;30(6):435-41. doi: 10.1002/hup.2495.

Temporary deep brain stimulation in Gilles de la Tourette syndrome: A feasible approach?

Zekaj E, Saleh C, Porta M, Servello D.

Surg Neurol Int. 2015 Jul 21;6:122. doi: 10.4103/2152-7806.161242.

Premonitory Urges in Patients with Gilles de la Tourette Syndrome: An Italian Translation and a 7-Year Follow-up.

Gulisano M, Calì P, Palermo F, Robertson M, Rizzo R.

J Child Adolesc Psychopharmacol. 2015 Dec;25(10):810-6. doi: 10.1089/cap.2014.0154.

Retraction Note to: Association of Catechol-O-methyltransferase val/met polymorphism with cognitive function in Gilles de la Tourette syndrome patients.

[No authors listed]

Neurol Sci. 2015 Oct;36(10):1983. doi: 10.1007/s10072-015-2306-y. No abstract available.

Histamine and histamine receptors in Tourette syndrome and other neuropsychiatric conditions.

Rapanelli M, Pittenger C.

Neuropharmacology. 2016 Jul;106:85-90. doi: 10.1016/j.neuropharm.2015.08.019. Review.

Are Motor Skills and Motor Inhibitions Impaired in Tourette Syndrome? A Review.

Kalsi N, Tambelli R, Aceto P, Lai C.

J Exp Neurosci. 2015 Jul 27;9:57-65. doi: 10.4137/JEN.S25095. Review.

[POSSIBILITY OF USING NESTED POLYMERASE CHAIN REACTION FOR DIAGNOS- TICS OF DISEASES CAUSED BY VARICELLA ZOSTER VIRUS].

Fam KhF, Borovikova EA, Sidorov AV, Karataeva AV, Antonova TP, Zverev VV.

Zh Mikrobiol Epidemiol Immunobiol. 2015 May-Jun;(3):25-30. Russian.

Support of positive association in family-based genetic analysis between COL27A1 and Tourette syndrome.

Liu S, Yu X, Xu Q, Cui J, Yi M, Zhang X, Ge Y, Ma X.

Sci Rep. 2015 Aug 3;5:12687. doi: 10.1038/srep12687.

The effectiveness and safety of plum-blossom needle therapy for Tourette syndrome: study protocol for a randomized controlled trial.

Yu J, Ye Y, Li S, Liu J, Zhai Y, Zhang M, Liu Z.

Trials. 2015 Jul 29;16:320. doi: 10.1186/s13063-015-0873-0.